Add BrightSurf on Google Email

Science News for September 1, 2003


Hot pepper chemical links tongue to heart

Researchers discovered that 'hot pepper' receptors on the heart trigger symptoms of heart attack and may lead to new treatments for angina pectoris. The study found that these receptors cause blood vessels to constrict and increase blood pressure, leading to chest pain.

SourcePenn State·JournalThe Journal of Physiology·DateSep 1, 2003

Annals of Internal Medicine, tip sheet, September 2, 2003

A recent study found treating older adults with the flu to be cost-effective, while a Hong Kong-based SARS study reveals higher-than-expected mortality rates, highlighting the need for more effective diagnostic tools.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateSep 1, 2003
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Articles on protected area management published in BioScience

A special section of BioScience provides in-depth analyses of assessment systems for protected area management effectiveness. Key findings include the need for more widespread use of assessments and monitoring, as well as the identification of critical management issues such as funding, staffing, and community relations.

SourceAmerican Institute of Biological Sciences·JournalBioScience·DateSep 1, 2003

Study shows brain activity influences immune function

A study published in the Proceedings of the National Academy of Sciences found that individuals with greater activity in the left side of the prefrontal cortex had a stronger immune response against disease. The researchers measured brain activity and immune function in 52 individuals between 57-60 years old, and found a positive corre...

SourceUniversity of Wisconsin-Madison·JournalProceedings of the National Academy of Sciences·DateSep 1, 2003

Dual action anthrax vaccine more effective

A new vaccine targets both the anthrax bacterium and its toxins, demonstrating improved effectiveness in mice tests. The dual-action approach also holds promise as a therapeutic vaccine to help those already infected control the bacteria over time.

SourceHarvard Medical School·JournalProceedings of the National Academy of Sciences·DateSep 1, 2003